Estrella Immunopharma, Inc.

ESLA·NASDAQ·$1.15Share Price as of 11/2·$49MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/13/26 10-QQ1 ended 03/31/2605/18/26 10-K/AFY 202504/30/26 10-KFY 202503/18/26 10-QQ3 ended 09/30/2511/12/25

Disclosures

8-KCurrent report10/29/26 8-KCurrent report09/08/26 8-KCurrent report08/21/26 8-KCurrent report06/30/26 8-KCurrent report01/13/26

Prospectuses and Registrations

424B3Prospectus02/13/26 S-1/ARegistration statement (amended)01/22/26 S-1/ARegistration statement (amended)01/16/26 424B5Prospectus supplement01/06/26 S-1Registration statement (IPO)12/22/25

Proxies

DEF 14ADefinitive proxy05/27/26 DEFA14AAdditional proxy materials07/26/23 DEFA14AAdditional proxy materials07/12/23 DEF 14ADefinitive proxy06/16/23 PRER14APreliminary proxy (revised)06/02/23

Ownership

Form 4Insider transaction08/26/26 Form 4Insider transaction08/25/26 SC 13G/ABeneficial ownership (amended)08/14/26 SC 13GBeneficial ownership05/15/26 Form 4Insider transaction04/29/26

Other

NT 10-QLate filing notification (10-Q)05/18/26 EFFECTRequest for effectiveness01/23/26 CORRESPCorrespondence with the SEC01/22/26 UPLOADLetter from the SEC12/29/25 10-KTFY 202403/25/25